Exosomal microRNAs in lung cancer: a narrative review
Authors:
- Zhe ZhangZZZhe Zhang
- Fengwu LinFLFengwu Lin
- Wenqi WuWWWenqi Wu
- Jingyuan JiangJJJingyuan Jiang
- Chen ZhangCZChen Zhang
- Dongliang QinDQDongliang Qin
- Zhenan XuZXZhenan Xu
Open Access
- 1 June 2024
- journal article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 13 (6) , 3090-3105
Abstract
Exosomes are nanoscale extracellular vesicles secreted by cells, which can release bioactive macromolecules, such as microRNA (miRNA) to receptor cells. Exosomes can efficiently penetrate various biological barriers which mediate intercellular communication. MiRNA are a class of non-coding RNA that primarily regulate messenger RNA (mRNA) at the post-transcriptional level. MiRNA is abundant in exosomes, which plays an important role by being transported and released through exosomes secreted by lung cancer cells. This review aims to elucidate the roles of exosome-derived miRNAs in lung cancer. We focused on the roles of exosome-derived miRNAs in cancer occurrence and development, including angiogenesis, cell proliferation, invasion, metastasis, immune escape, drug resistance, and their clinical value as new diagnostic and prognostic markers for lung cancer. Exosomal miRNA can not only affect angiogenesis of lung cancer, induce epithelial-mesenchymal transformation, and promote reprogramming of tumor microenvironment, but also affect immune regulation and drug resistance transmission and participate in regulating lung cancer cell proliferation. Therefore, understanding the regulatory roles of exosomal miRNAs in tumor invasion and metastasis can provide new ideas for the treatment of lung cancer. Exosomal miRNA can provide some unique ideas on how to improve the efficiency of diagnosis and treatment of lung cancer in the future. Targeting tumor-specific exosomal miRNA represents a new strategy for clinical treatment of lung cancer, which can provide potential non-invasive biomarkers in the early diagnosis of lung cancer. Investigation of the involvement of exosomal miRNAs in the occurrence and progression of tumors can yield new opportunities for the clinical diagnosis and treatment of lung cancer.Keywords
This publication has 100 references indexed in Scilit:
- microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung CancerJournal of Thoracic Oncology, 2013
- Exosomal Tumor MicroRNA Modulates Premetastatic Organ CellsNeoplasia, 2013
- Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell typesBMC Genomics, 2012
- MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory responseProceedings of the National Academy of Sciences, 2012
- MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cellsInternational Journal of Oncology, 2012
- Andrographolide sensitizes cisplatin-induced apoptosis via suppression of autophagosome-lysosome fusion in human cancer cellsAutophagy, 2012
- The microenvironment in breast cancer progression: biology and implications for treatmentBreast Cancer Research, 2011
- Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living CellsJournal of Biological Chemistry, 2010
- Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T LymphocytesThe Journal of Immunology, 2009
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNature Cell Biology, 2008